Common side effects include mild injection site reactions (such as pain, redness, or swelling), headache, flushing, dizziness, and nausea
AOD-9604 is administered subcutaneously with a half-life of approximately 23 hours in humans (measured in Phase 2 trials), also requiring daily dosing
This needleless injector will set you free
There is no standardized product to study, which is part of why the evidence base is so thin
I do everything in my power to protect the integrity of the vials so they are as potent as possible
While this may have partially biased our results, the baseline difference was not statistically significant, further strengthening the evidence for the efficacy of Sucrosomial B12